ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...

The lower dose was associated with the need for an additional epinephrine dose, epinephrine infusion, or intubation compared ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fear of needles may delay treatment with injectable ...

neffy contains epinephrine, a medicine used to treat allergic emergencies (anaphylaxis). Anaphylaxis can be life-threatening, can happen in minutes, and can be caused by stinging and biting insects, ...

The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...

Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...

EpiPen (epinephrine) is a brand-name injection prescribed for the emergency treatment of a severe allergic reaction in adults and children. As with other drugs, EpiPen can cause side effects, such as ...

Credit: ARS Pharma. Neffy is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. With regard to cardiovascular effects, increases in blood pressure and ...

If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...

After Kate Sambuco’s 11-year-old son, Cole, was diagnosed with allergies to peanuts, tree nuts, and dairy, she found a source of ongoing anxiety was the delivery method necessary to treat his episodes ...

Please provide your email address to receive an email when new articles are posted on . Aquestive aims to submit a new drug application in the first quarter of 2025. The company hopes to launch in ...